Medicaid expansion improves cancer survival outcomes for young adults, Winship study finds

With five-year cancer survival at an all-time high, does this mean people are living longer?

“It's really, really important that every year since 1991, cancer mortality has dropped by a little bit, and it did again!” said Paul Goldberg, editor and publisher of The Cancer Letter. “Now, mortality is a good metric, age-adjusted mortality. As far as survival, well, that's not so good.”

January 21, 2026

Clinical Health Equity

New Medicaid work requirements could lead to 1.6 million missed cancer screenings over two years

New Medicaid work requirements included in President Donald Trump’s “One Big Beautiful Bill Act” could result in as many as 1.6 million missed screenings for breast, colon, and lung cancers within the first two years, researchers at the University of Chicago reported in a paper published in JAMA Oncology earlier this month.

When “safe and effective” is not “reasonable and necessary”
We can curb excessive drug dosing and improve the quality of cancer care

By law, the Food and Drug Administration is required to determine whether a drug, device, biologic, or medical device is “safe and effective.” But the FDA determination does not control whether the Centers for Medicare & Medicaid Services will pay for it. To satisfy CMS, medical products and services must be “reasonable and necessary,” meaning...

January 16, 2026

Vol.52 No.02

By Mark J. Ratain and David A. Hyman

Clinical Roundup

Patients in Nepal experience substantial delays when accessing cancer care, study finds

Substantial delays are taking place across the cancer care pathway in Nepal, with many patients waiting months between first symptoms and treatment, according to an article by the International Agency for Research on Cancer and partners.

December 05, 2025

Vol.51 No.44

Cancer Policy

CMS announces GENEROUS drug payment model aimed at lowering Medicaid drug prices

CMS announced a new drug payment model called the GENErating cost Reductions for U.S. Medicaid (GENEROUS) Model that the agency plans to pilot next year.

November 14, 2025

Vol.51 No.42

By Sara Willa Ernst and Jacquelyn Cobb

Podcast The Directors

The Directors: Ruben Mesa and Kunle Odunsi on how immigration and diversity accelerate discovery
“This has always made our environment stronger, not weaker.”

At a time when federal immigration policies are becoming stricter, Kunle Odunsi, director of University of Chicago Medicine Comprehensive Cancer Center, reflected on the fact that cancer research is a highly international community.

November 07, 2025

Vol.51 No.41

By Jacquelyn Cobb and Paul Goldberg

Medicaid expansion improves cancer survival outcomes for young adults, Winship study finds

YOU MAY BE INTERESTED IN

With five-year cancer survival at an all-time high, does this mean people are living longer?

New Medicaid work requirements could lead to 1.6 million missed cancer screenings over two years

When “safe and effective” is not “reasonable and necessary”
We can curb excessive drug dosing and improve the quality of cancer care

Patients in Nepal experience substantial delays when accessing cancer care, study finds

CMS announces GENEROUS drug payment model aimed at lowering Medicaid drug prices

The Directors: Ruben Mesa and Kunle Odunsi on how immigration and diversity accelerate discovery
“This has always made our environment stronger, not weaker.”

Renew today!

Subscriber content

Never miss an issue!

Login

Medicaid expansion improves cancer survival outcomes for young adults, Winship study finds

YOU MAY BE INTERESTED IN

With five-year cancer survival at an all-time high, does this mean people are living longer?

New Medicaid work requirements could lead to 1.6 million missed cancer screenings over two years

When “safe and effective” is not “reasonable and necessary”We can curb excessive drug dosing and improve the quality of cancer care

Patients in Nepal experience substantial delays when accessing cancer care, study finds

CMS announces GENEROUS drug payment model aimed at lowering Medicaid drug prices

The Directors: Ruben Mesa and Kunle Odunsi on how immigration and diversity accelerate discovery“This has always made our environment stronger, not weaker.”

Never miss an issue!

Login

When “safe and effective” is not “reasonable and necessary”
We can curb excessive drug dosing and improve the quality of cancer care

The Directors: Ruben Mesa and Kunle Odunsi on how immigration and diversity accelerate discovery
“This has always made our environment stronger, not weaker.”